Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Loxapina para la esquizofrenia

Información

DOI:
https://doi.org/10.1002/14651858.CD001943.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 17 octubre 2007see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Esquizofrenia

Copyright:
  1. Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Abhijit Chakrabarti

    Correspondencia a: Becklin Centre, Leeds, UK

    [email protected]

  • Anne‐Marie Bagnall

    Faculty of Health and Social Sciences, Leeds Beckett University, Leeds, UK

  • Pierre Chue

    Department of Psychiatry, University of Alberta, Edmonton, Canada

  • Mark Fenton

    Database of Uncertainties about the Effects of Treatments (DUETs), National Institute for Health and Clinical Excellence, Manchester, UK

  • Vikram Palanisamy

    East Cheshire Learning Disability Team, Cheshire and Wirral Partnership NHS Foundation Trust, Macclesfield, UK

  • Winson Wong

    Health Education Yorkshire and the Humber, Sheffield, UK

  • Jun Xia

    Cochrane Schizophrenia Group, The University of Nottingham, Nottingham, UK

Contributions of authors

Contributions:
Mark Fenton ‐ prepared protocol, selected and acquired studies, extracted data, summated data, produced report.

Brendan Murphy ‐protocol writing, selected studies, extracted data, summated data.

Anne‐Marie Bagnall ‐ prepared protocol, undertook searches, selected and acquired studies, extracted data, summated data, produced report..

Pierre Chue ‐ data extraction from French studies, report writing.

Maria Leitner ‐ finding funding, inital input into the protocol and searches.

Sources of support

Internal sources

  • Leeds Social Services, UK.

  • Jansen Cilag, UK.

  • Centre for Reviews and Dissemination, University of York, UK.

  • Cochrane Schizophrenia Group, UK.

External sources

  • Centre for Reviews and Dissemination, University of York., UK.

Declarations of interest

Mark Fenton has lead Janssen, Lilly and Zeneca sponsored workshops for clinicians.

Jo Wood is Medical Information Officer for Janssen Cilag UK, and worked on this review to increase her knowledge of the process of systematic reviewing.

The Cochrane Schizophrenia Group has received general support funding from Eli Lilly during the years 1996‐9 (see Group Module).

Acknowledgements

Thanks to Julie Glanvile from the Centre for Reviews and Dissemination, University of York who undertook all electronic searches of the original search in 1999 and to Judy Wright from the Cochrane Schizophrenia group who undertook electronic searches for the 2007 update. Thanks to Evandro Coutinho who provided translation for a Brazilian study and Tessa Grant who provided translation for a French study. Thanks to Professor Clive Adams and Ajit Kumar for their support.

Jo Wood helped select studies, extract data, summate data and produce the original report in 2008. She has not been involved in the writing of subsequent versions. We would like to thank her for these previous contributions.

Version history

Published

Title

Stage

Authors

Version

2007 Oct 17

Loxapine for schizophrenia

Review

Abhijit Chakrabarti, Anne‐Marie Bagnall, Pierre Chue, Mark Fenton, Vikram Palanisamy, Winson Wong, Jun Xia

https://doi.org/10.1002/14651858.CD001943.pub2

2000 Jan 24

Loxapine for schizophrenia

Review

Brendan Eugene Murphy, Anne‐Marie Bagnall, Pierre Chue, Mark Fenton, Maria Leitner, Jo Wood

https://doi.org/10.1002/14651858.CD001943

Notes

Cochrane Schizophrenia Group internal peer review complete (see Module).
External peer review scheduled.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.